Scinai Immunotherapeutics Stock Alpha and Beta Analysis
| SCNI Stock | USD 0.76 0.04 5.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Scinai Immunotherapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Scinai Immunotherapeuti over a specified time horizon. Remember, high Scinai Immunotherapeuti's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Scinai Immunotherapeuti's market risk premium analysis include:
Beta 3.46 | Alpha (1.00) | Risk 6.6 | Sharpe Ratio (0.10) | Expected Return (0.67) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Scinai Immunotherapeuti Backtesting, Scinai Immunotherapeuti Valuation, Scinai Immunotherapeuti Correlation, Scinai Immunotherapeuti Hype Analysis, Scinai Immunotherapeuti Volatility, Scinai Immunotherapeuti History and analyze Scinai Immunotherapeuti Performance. Scinai Immunotherapeuti Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Scinai Immunotherapeuti market risk premium is the additional return an investor will receive from holding Scinai Immunotherapeuti long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Scinai Immunotherapeuti. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Scinai Immunotherapeuti's performance over market.| α | -1 | β | 3.46 |
Scinai Immunotherapeuti expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Scinai Immunotherapeuti's Buy-and-hold return. Our buy-and-hold chart shows how Scinai Immunotherapeuti performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Scinai Immunotherapeuti Market Price Analysis
Market price analysis indicators help investors to evaluate how Scinai Immunotherapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Scinai Immunotherapeuti shares will generate the highest return on investment. By understating and applying Scinai Immunotherapeuti stock market price indicators, traders can identify Scinai Immunotherapeuti position entry and exit signals to maximize returns.
Scinai Immunotherapeuti Return and Market Media
The median price of Scinai Immunotherapeuti for the period between Thu, Sep 25, 2025 and Wed, Dec 24, 2025 is 1.23 with a coefficient of variation of 19.0. The daily time series for the period is distributed with a sample standard deviation of 0.23, arithmetic mean of 1.21, and mean deviation of 0.2. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Is Scinai Immunotherapeutics Ltd. stock supported by free cash flow - Portfolio Return Summary Precise Buy Zone Tips - newser.com | 10/23/2025 |
2 | How Scinai Immunotherapeutics Ltd. stock compares with market leaders - 2025 Dividend Review Stepwise Trade Execution Plans - newser.com | 10/30/2025 |
3 | Scinai Immunotherapeutics Announces December 2025 Shareholder Meeting - TipRanks | 11/13/2025 |
4 | Will Scinai Immunotherapeutics Ltd. stock split increase liquidity - Market Sentiment Review Technical Entry and Exit Alerts - newser.com | 11/19/2025 |
5 | How Scinai Immunotherapeutics Ltd. stock reacts to new regulations - Weekly Volume Report Weekly High Conviction Ideas - Newser | 12/04/2025 |
6 | Gap Down How analysts revise price targets for Scinai Immunotherapeutics Ltd. stock - Earnings Risk Summary High Accuracy Trade Alerts - ulpravda.ru | 12/19/2025 |
About Scinai Immunotherapeuti Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Scinai or other stocks. Alpha measures the amount that position in Scinai Immunotherapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Payables Turnover | 3.29 | 3.46 | Days Of Inventory On Hand | 0.00413 | 0.007784 |
Scinai Immunotherapeuti Upcoming Company Events
As portrayed in its financial statements, the presentation of Scinai Immunotherapeuti's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Scinai Immunotherapeuti's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Scinai Immunotherapeuti's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Scinai Immunotherapeuti. Please utilize our Beneish M Score to check the likelihood of Scinai Immunotherapeuti's management manipulating its earnings.
| 15th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Scinai Immunotherapeuti
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Scinai Immunotherapeuti Backtesting, Scinai Immunotherapeuti Valuation, Scinai Immunotherapeuti Correlation, Scinai Immunotherapeuti Hype Analysis, Scinai Immunotherapeuti Volatility, Scinai Immunotherapeuti History and analyze Scinai Immunotherapeuti Performance. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Scinai Immunotherapeuti technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.